China Jo-Jo Drugstores, Inc.
CJJD · NASDAQ
9/30/2024 | 3/31/2024 | 9/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | -3.3% | 3.3% | – |
| Cost of Goods Sold | – | $0 | $0 | $0 |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | 20% | 20.3% | 22.8% |
| R&D Expenses | – | $0 | $0 | $0 |
| G&A Expenses | – | $0 | $0 | $0 |
| SG&A Expenses | – | $0 | $0 | $0 |
| Sales & Mktg Exp. | – | $0 | $0 | $0 |
| Other Operating Expenses | – | $0 | $0 | $0 |
| Operating Expenses | – | $0 | $0 | $0 |
| Operating Income | – | -$0 | $0 | -$0 |
| % Margin | – | -5% | 0.3% | -25.9% |
| Other Income/Exp. Net | – | $0 | -$0 | -$0 |
| Pre-Tax Income | – | -$0 | -$0 | -$0 |
| Tax Expense | – | $0 | $0 | -$0 |
| Net Income | – | -$0 | -$0 | -$0 |
| % Margin | – | -4.4% | -1.2% | -27% |
| EPS | – | -1.96 | -0.78 | -25.9 |
| % Growth | – | -151.3% | 97% | – |
| EPS Diluted | – | -1.96 | -0.78 | -25.9 |
| Weighted Avg Shares Out | – | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | – | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $0 | $0 | $0 |
| EBITDA | – | -$0 | $0 | -$0 |
| % Margin | – | -4% | 0.7% | -25.8% |